Alpha 2.0
Login Register
» Authors » Barbora Belsanova

Barbora Belsanova

Explore the profile of Barbora Belsanova including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 137
Followers 0
Related Specialties
Oncology
Chemistry
General Medicine
Top 10 Co-Authors
Marek Minarik
Lucie Benesova
Miroslav Zavoral
Tereza Halkova
Milos Pesek
Petra Minarikova
Stepan Suchanek
Bohus Bunganic
Ludmila Lipska
Eva Traboulsi
Published In
Anticancer Res
J Sep Sci
Cancer Genet
World J Gastroenterol
Pathol Oncol Res
Affiliations
Soon will be listed here.
Recent Articles
11.
Utility of cell-free tumour DNA for post-surgical follow-up of colorectal cancer patients
Levy M, Benesova L, Lipska L, Belsanova B, Minarikova P, Veprekova G, et al.
Anticancer Res . 2012 May; 32(5):1621-6. PMID: 22593440
Background: While efficient surgical treatment is the key to prolonged survival of patients with colorectal cancer, post-surgical follow-up is important for the early detection of relapsing disease or of disease...
12.
A novel high-resolution chipCE assay for rapid detection of EGFR gene mutations and amplifications in lung cancer therapy by a combination of fragment analysis, denaturing CE and MLPA
Minarik M, Gassman M, Belsanova B, Pesek M, Schouten J, Chudoba R, et al.
Electrophoresis . 2010 Oct; 31(21):3518-24. PMID: 20967766
There is a growing interest in evaluating molecular markers as predictors of response to new generation of targeted cancer therapies. One of such areas is biological therapy targeting epidermal growth...
13.
Multiplicity of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC) patients treated with tyrosine kinase inhibitors
Benesova L, Minarik M, Jancarikova D, Belsanova B, Pesek M
Anticancer Res . 2010 Jul; 30(5):1667-71. PMID: 20592359
Background: Concurrent presence of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC) patients is relatively rare and their appearance is believed to be mutually exclusive. Tumours harbouring KRAS...
14.
Denaturing capillary electrophoresis for automated detection of L858R mutation in exon 21 of the epidermal growth factor receptor gene in prediction of the outcome of lung cancer therapy
Benesova L, Pesek M, Belsanova B, Sekerka P, Minarik M
J Sep Sci . 2010 Jun; 33(15):2349-55. PMID: 20574956
The presence of activating mutations within the tyrosine kinase domain of the epidermal growth factor receptor gene has been attributed to a positive response to biological therapy of lung cancer...
15.
Dominance of EGFR and insignificant KRAS mutations in prediction of tyrosine-kinase therapy for NSCLC patients stratified by tumor subtype and smoking status
Pesek M, Benesova L, Belsanova B, Mukensnabl P, Bruha F, Minarik M
Anticancer Res . 2009 Jul; 29(7):2767-73. PMID: 19596959
Background: Therapy by tyrosine kinase inhibitors (TKI) has become inevitable in treatment of advanced NSCLC. Mutations in EGFR and KRAS genes have been identified as the main potential predictive and...